Clinical trial
O6-benzylguanine and Carmustine in Treating Patients With Stage IA-IIA Cutaneous…
NCT00003613 · National Cancer Institute (NCI), NIH · Terminated
Key facts
| NCT number | NCT00003613 |
|---|---|
| Title | O6-benzylguanine and Carmustine in Treating Patients With Stage IA-IIA Cutaneous T-cell Lymphoma |
| Official title | Phase I Trial of O6 Benzylguanine and BCNU in Cutaneous T-cell Lymphoma |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Terminated |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma, Stage I Cutaneous T-cell Non-Hodgkin Lymphoma, Stage II Cutaneous T-cell Non-Hodgkin Lymphoma |
| Intervention type | Drug, Other |
| Interventions | O6-benzylguanine, carmustine, laboratory biomarker analysis |
| Enrollment | 20 |
| Start date | Apr 1, 1999 |
| Primary completion | May 1, 2006 |
| First posted | Jan 27, 2003 |
| Last update posted | Jan 11, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: